What is Blood Analyzers Market?
To assess blood components, a blood analyzer is used. Hospitals, diagnostic labs, forensic laboratories, and people at home use blood analyzers. An analyzer for blood chemistry can be used to evaluate numerous items, for instance, blood cell counts, medicinal drug screening, illegal drug use, blood typing, protein analysis, thyroid function testing, and antibodies checking. Blood analyzers use numerous tests, including cell counters to perform blood counts, immunoassays to detect antibodies, ion tests to measure voltage differences, and enzyme presence tests to detect enzyme activity through a physical change in the sample.
Highlights from Blood Analyzers Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Sysmex Corporation (Japan), Medtronic plc (United States), Bayer AG (Germany), Danaher (United States), Abbott Laboratories (United States), Nihon Kohden (Japan), Siemens (Germany), Bio-Rad Laboratories (United States), BioSystems (Spain), Diatron (Hungary), Roche (Switzerland) and Fisher Scientific International, Inc. (United States) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new product launches, and collaborations as their preferred strategies. The players explore new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Blood Analyzers market throughout the forecasted period.
Sysmex Corporation (Japan), Medtronic plc (United States), Bayer AG (Germany), Danaher (United States), Abbott Laboratories (United States), Nihon Kohden (Japan), Siemens (Germany), Bio-Rad Laboratories (United States), BioSystems (Spain), Diatron (Hungary), Roche (Switzerland) and Fisher Scientific International, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Drew Scientific (United States), EKF Diagnostics (United Kingdom), Mindray (China), Ortho Clinical Diagnostics (United States), Beckman Coulter, Inc. (United States), Boule Diagnostics (Sweden) and HORIBA (Japan). Blood Analyzers Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Hospital, Laboratories {Medical Labs, Forensic Labs}, Research and Academic Institutes, Pathology and Others |
Distribution Channel | Online,Offline |
Display | LED,LCD,TFT,Others |
Automatic Grade | Automatic Blood Analyzers,Manual Blood Analyzers,Semiautomatic Blood Analyzers |
On the basis of geography, the market of Blood Analyzers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Technology Advancement regarding Blood Analyzers
Market Growth Drivers:
Increase in Blood Donation and Growing Incidence of Blood Disorders
Challenges:
Problem-related to the High Cost of Advanced Hematology Analyzers
Restraints:
Issue related to Slow Adoption of Advanced Hematology Instruments in Emerging Countries
Opportunities:
Growing Demand from Emerging Economics such as China, India, among others and Rising Use of Automated Hematology Analyzers
Key Target Audience
Blood Analyzers Manufacturer Company, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others
Market Leaders & Development Strategies
In February 2018, McKesson and Sysmex signed a distribution deal for Sysmex’s XW-100 automated hematology analyzers in the United States.
In May 2022, Nihon Kohden established a new hematology analyzer reagent factory in India. This leads to an increase in production capacity and strengthens its business structure.
According to Medical Media, LLC, “For hematology analyzers, the verification or validation process breaks down into several essential elements: Accuracy, precision, reportable range, reference intervals, and evaluation of instrument flags. In general, the laboratory should follow manufacturer-recommended protocols for conducting the studies (under the discretion of the laboratory medical director), while incorporating recommendations and requirements from accreditation and regulatory agencies.” Hence, it may act as a hamper for market growth.